Related Experiment Video
Updated: Jul 28, 2025

08:17
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
15.8K
Joint radial trajectory correction for accelerated T2 * mapping on an MR-Linac
Wajiha Bano1, Will Holmes1, Rosie Goodburn1
1Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK.
Medical Physics
|May 28, 2023
Summary
This study demonstrates an accelerated T2* mapping technique using trajectory auto-correction (TrACR) for MR-guided radiotherapy. The method improves image quality and allows for faster acquisition, enabling adaptive radiotherapy on MR-Linacs.
Area of Science:
- Medical Imaging
- Radiotherapy Physics
- Quantitative MRI
Background:
- T2* mapping can characterize tumor hypoxia, a factor in therapy resistance.
- Acquiring T2* maps during MR-guided radiotherapy could enable treatment adaptation.
- Hypoxia-associated therapy resistance may be overcome by dose escalation to resistant sub-volumes.
Purpose of the Study:
- To demonstrate the feasibility of accelerated T2* mapping using model-based reconstruction with integrated trajectory auto-correction (TrACR).
- To validate the technique for MR-guided radiotherapy on an MR-Linear accelerator (MR-Linac).
Main Methods:
- Validated a novel accelerated T2* mapping technique using model-based reconstruction with integrated trajectory auto-correction (TrACR).
- Compared sequential and joint T2* mapping approaches in numerical phantoms with varying noise levels and gradient delays.
- Acquired in vivo data from prostate and head and neck cancer patients undergoing MR-Linac treatment, comparing reconstructed T2* maps with and without trajectory corrections.
Main Results:
- Numerical simulations showed the joint approach with TrACR reduced errors in T2* maps compared to uncorrected and sequential methods across all noise levels.
- In vivo data demonstrated that TrACR resulted in fewer artifacts and improved visual quality of T2* maps.
- Reconstructed T2* maps from different treatment fractions revealed changes within the planning target volume (PTV) for both patient types.
Conclusions:
- The proposed approach enables retrospective, data-driven gradient delay correction, crucial for hybrid MR-Linac devices.
- Accelerated T2* maps were acquired in under 5 minutes, suitable for integration into MR-guided radiotherapy workflows.
- This technique supports online adaptive radiotherapy by minimizing patient burden and allowing time for additional imaging.

